Validation of the German version of the patient activation measure 13 (PAM13-D) in an international multicentre study of primary care patients

PLoS One. 2013 Sep 30;8(9):e74786. doi: 10.1371/journal.pone.0074786. eCollection 2013.

Abstract

The patients' active participation in their medical care is important for patients with chronic diseases. Measurements of patient activation are needed for studies and in clinical practice. This study aims to validate the Patient Activation Measure 13 (PAM13-D) in German-speaking primary care patients. This international cross-sectional multicentre study enrolled consecutively patients from primary care practices in three German-speaking countries: Germany, Austria, and Switzerland. Patients completed the PAM13-D questionnaire. General Self-Efficacy scale (GSE) was used to assess convergent validity. Furthermore Cronbach's alpha was performed to assess internal consistency. Exploratory factor analysis was used to evaluate the underlying factor structure of the items. We included 508 patients from 16 primary care practices in the final analysis. Results were internally consistent, with a Cronbach's alpha of 0.84. Factor analysis revealed one major underlying factor. The mean values of the PAM13-D correlated significantly (r = 0.43) with those of the GSE. The German PAM13 is a reliable and valid measure of patient activation. Thus, it may be useful in primary care clinical practice and research.

Publication types

  • Multicenter Study
  • Validation Study

MeSH terms

  • Austria
  • Cross-Sectional Studies
  • Factor Analysis, Statistical
  • Germany
  • Humans
  • Linear Models
  • Patient Participation / statistics & numerical data*
  • Patients / psychology*
  • Primary Health Care*
  • Surveys and Questionnaires
  • Switzerland

Grant support

These authors have no support or funding to report.